Allogeneic NK cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic NK cells, covering 2026-03-11 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients [Phase 1, Phase 2]